ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 52 filers reported holding ADC THERAPEUTICS SA in Q4 2020. The put-call ratio across all filers is 5.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $160,584 | +10.3% | 74,690 | 0.0% | 0.00% | – |
| Q1 2023 | $145,646 | -49.2% | 74,690 | 0.0% | 0.00% | – |
| Q4 2022 | $286,810 | -21.4% | 74,690 | 0.0% | 0.00% | – |
| Q3 2022 | $365,000 | -50.3% | 74,690 | -19.1% | 0.00% | -100.0% |
| Q2 2022 | $734,000 | -45.9% | 92,290 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,356,000 | -27.3% | 92,290 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $1,864,000 | -25.6% | 92,290 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $2,507,000 | +41.4% | 92,290 | +9.5% | 0.00% | +50.0% |
| Q2 2021 | $1,773,000 | -13.8% | 84,290 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,058,000 | +22.5% | 84,290 | +60.6% | 0.00% | 0.0% |
| Q4 2020 | $1,680,000 | – | 52,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $33,939,000 | 9.12% |
| Redmile Group, LLC | 7,451,029 | $150,511,000 | 3.42% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $30,648,000 | 3.17% |
| Indie Asset Partners, LLC | 96,582 | $1,951,000 | 1.42% |
| MPM BioImpact LLC | 337,396 | $6,815,000 | 1.24% |
| Eventide Asset Management | 1,975,000 | $39,895,000 | 0.51% |
| HHLR ADVISORS, LTD. | 500,000 | $10,100,000 | 0.16% |
| Virtus ETF Advisers LLC | 19,193 | $388,000 | 0.15% |
| CNA FINANCIAL CORP | 15,245 | $308,000 | 0.08% |
| Employees Retirement System of Texas | 278,000 | $5,616,000 | 0.06% |